To access the professional site for information about BETASERON® (interferon beta-1b) please confirm that you are a healthcare professional.
You will only be prompted once per visit to the website.
BETASERON® (interferon beta-1b) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
When you become a BETASERON® patient, BETAPLUS provides you with personalized one-on-one support throughout your treatment. That includes an MS-trained BETA Nurse available 24/7, training and helpful tools, practical resources, financial assistance, and more.
in copay assistance each calendar year*
if you experience insurance challenges†
or are receiving coverage through
Medicare Part D
Your doctor makes treatment decisions based on the best information available. Give them the most accurate information you can.‡ The BETACONNECT system empowers you to automatically capture your injection information and share it with your BETA Nurse and healthcare team.‡
The first and only electronic autoinjector for relapsing forms of MS powered by Bluetooth® technology, so you can automatically track your injections.‡
Leave behind the days of manual tracking by sharing your real-time data with your BETA Nurse and healthcare team.‡ Sync myBETAapp with your BETACONNECT autoinjector to keep track of your injections.
A BETA Nurse gets to know you, and when you share your injection data using myBETAapp, the BETA Nurse can follow your progress and provide proactive support.‡ Your healthcare team, including your doctor and pharmacist, can also view your injection data via the BETACONNECT™ Navigator to support your care.‡
It is important to share with your BETA Nurse and your healthcare team.‡ Only you, your BETA Nurse and your healthcare team can see your injection data, and have informed discussions to:
‡When using the BETACONNECT autoinjector, injection data are automatically transferred to myBETAapp whenever the autoinjector is powered on and within range of a patient’s mobile device. myBETAapp must be open and running in order for data transfer to occur. Healthcare professionals must have BETACONNECT Navigator access, and a patient must enable sharing in myBETAapp for HCPs to obtain this information. Please note: If a patient is not using BETACONNECT to administer injections, he/she can also record injections manually. Patients are able to modify the details or delete injection data manually recorded in myBETAapp.
— Camille, a BETASERON patient